Trials / Unknown
UnknownNCT03810521
Dose-escalation of Cellistem-OA in Patients With Knee Osteoarthritis
A Phase I Dose-escalation Trial to Assess Safety and Efficacy of Cellistem-OA in Patients With Knee Osteoarthritis (CLT-OA1)
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Universidad de los Andes, Chile · Academic / Other
- Sex
- All
- Age
- 30 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A phase I dose-escalation trial to assess safety and efficacy of allogeneic MSC based-treatment (cellistem-OA) in patients with symptomatic knee osteoarthritis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | umbilical cord derived-mesenchymal stromal cells | Intra-articular infiltration of umbilical cord derived-mesenchymal stromal cells |
Timeline
- Start date
- 2019-03-01
- Primary completion
- 2019-10-30
- Completion
- 2019-12-30
- First posted
- 2019-01-18
- Last updated
- 2019-01-18
Locations
1 site across 1 country: Chile
Source: ClinicalTrials.gov record NCT03810521. Inclusion in this directory is not an endorsement.